Quest PharmaTech Inc.
QPTFF · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $43 | $65 | $57 | $102 |
| G&A Expenses | $181 | $82 | $61 | $176 |
| SG&A Expenses | $181 | $92 | $61 | $176 |
| Sales & Mktg Exp. | $0 | $10 | $0 | $0 |
| Other Operating Expenses | -$52 | -$44 | $0 | $0 |
| Operating Expenses | $172 | $113 | $117 | $277 |
| Operating Income | -$172 | -$113 | -$117 | -$277 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $941 | -$14 | $812 | -$1,417 |
| Pre-Tax Income | $769 | -$127 | $695 | -$1,694 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $769 | -$127 | $695 | -$1,694 |
| % Margin | – | – | – | – |
| EPS | 0.005 | -0.001 | 0.004 | -0.01 |
| % Growth | 560% | -124.4% | 141% | – |
| EPS Diluted | 0.005 | -0.001 | 0.004 | -0.01 |
| Weighted Avg Shares Out | 169,129 | 169,233 | 169,129 | -343,698 |
| Weighted Avg Shares Out Dil | 169,129 | 169,129 | 169,129 | -338,258 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $4 | $5 | $0 |
| Depreciation & Amortization | $0 | $157 | $117 | $1 |
| EBITDA | -$118 | -$61 | $817 | -$1,693 |
| % Margin | – | – | – | – |